Asia PacificRhinoconjunctivitis Market By Treatment (Decongestants, Mast-Cell Stabilizers, Antihistamines, Nonsteroidal Anti-Inflammatory Drugs, And Intranasal Corticosteroids)and By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia PacificRhinoconjunctivitis Market By Treatment (Decongestants, Mast-Cell Stabilizers, Antihistamines, Nonsteroidal Anti-Inflammatory Drugs, And Intranasal Corticosteroids)and By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 5518 | Pages: 145 | December 2017 | Region: Asia Pacific


The Asia PacificRhinoconjunctivitis Market is worth USD xx million in 2016 and estimated to grow at a CAGR ofxx.xx%, to reach USD xx million by 2021. The Asia PacificRhinoconjunctivitis market is developing at an exceptionally quick pace.

Rhinoconjunctivitis refers to a medical condition which is a combination of rhinitis and conjunctivitis and is one of the most common allergic reactions worldwide. It is an inflammatory disorder that affects nasal and conjunctival mucosa and is caused due to result of hypersensitive immune response. Sneezing, watery mucus, itchy nose, and nasal congestion, as well as conjunctivitis which include burning sensation, tears and redness of eyes are some of the common symptoms of Rhinoconjunctivitis. Poor sleep, irritability and fatigue are also some of the symptoms. According to an article published in Journal of Allergy and Therapy, allergic rhinitis is one of the most common reasons for hospital visits due to allergies.

Increasing awareness about Rhinoconjunctivitis is expected to be the major growth factor during the forecast period. Also improving medical infrastructure, increasing spending on healthcare and increasing number of pharmaceutical players involved in R&D in developing nations is expected to boost this industry.

The Asia PacificRhinoconjunctivitis market is segmented on the basis of Treatmentand region. Based on treatmentthe market is segmented intoDecongestants, Mast-Cell Stabilizers, Antihistamines, Nonsteroidal Anti-Inflammatory Drugs, and Intranasal Corticosteroids. In case of frequent symptoms intra-nasal corticosteroids are prescribed which include Avamys, Flonase, and Nasacort etc. If symptoms are occasional Claritin, Reactine (cetirizine), Aerius, Allegra (fexofenadine) are prescribed.

Asia Pacific is geographically segmented into China, India, Japan, South Korea, Taiwan, Australia and South East Asia. Asia Pacific had the largest market and was also the fastest growing region. Factors like huge population, government initiatives and improving healthcare facilities in countries like China and India is expected to boost the industry in this region.

Johnson & Johnson Inc., Merck & Co., Inc., GlaxoSmithKline, Sanofi Adiga Life Sciences Inc. are the some key players in the Asia PacificRhinoconjunctivitismarket.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Decongestants      

                                5.1.3 Mast-Cell Stabilizers            

                                5.1.4 Antihistamines      

                                5.1.5 Nonsteroidal Anti-Inflammatory Drugs       

                                5.1.6 Intranasal Corticosteroids 

                                5.1.7  Y-o-Y Growth Analysis, By Treatment         

                                5.1.8  Market Attractiveness Analysis, By Treatment       

                                5.1.9  Market Share Analysis, By Treatment        

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Johnson & Johnson Inc.                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GlaxoSmithKline                       

                8.3 Sanofi                           

                8.4 Merck & Co., Inc.                     

                8.5 HAL Allergy                 

                8.6 Stallergens S.A.                         

                8.7 ALK-Abello A/S                         

                8.8 BioTech Tools s.a.                    

                8.9 Lofarma S.p.A.                          

                8.10  Adiga Life Sciences Inc.                      

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Rhinoconjunctivitis Market By Treatment, From 2016-2022 ( USD Million )
  2. Asia Pacific  Decongestants Market By Region, From 2016-2022 ( USD Million )
  3. Asia Pacific Mast-Cell Stabilizers Market By Region, From 2016-2022 ( USD Million )
  4. Asia Pacific Antihistamines Market By Region, From 2016-2022 ( USD Million )
  5. Asia Pacific Nonsteroidal Anti-Inflammatory Drugs Market By Region, From 2016-2022 ( USD Million )
  6. Asia Pacific Intranasal Corticosteroids Market By Region, From 2016-2022 ( USD Million )
  7. Japan Rhinoconjunctivitis Market By Treatment, From 2016-2022 ( USD Million )
  8. China Rhinoconjunctivitis Market By Treatment, From 2016-2022 ( USD Million )
  9. India Rhinoconjunctivitis Market By Treatment, From 2016-2022 ( USD Million )
  10. Australia Rhinoconjunctivitis Market By Treatment, From 2016-2022 ( USD Million )
  11. South Korea Rhinoconjunctivitis Market By Treatment, From 2016-2022 ( USD Million )
Middle East And Africa Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Gr...
Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Asia Pacific Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tren...
Europe Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, An...
North America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region Global (Industry Analysis, Size, Share, Growth, Trends, An...
Middle East And Africa Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022...
Latin America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Asia Pacific Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Europe Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
North America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.